"Our study suggests that besides obesity and diabetes, GLP-1-agonists may also help in the ... Decotiis also mentioned a new ...

Kennedy Jr., who has been tapped by Trump to lead the HHS, has been critical of Ozempic and other weight loss drugs.

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Here’s what to know about Tori Spelling’s weight loss journey in her own words. Spelling revealed in April on her podcast ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...